These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

355 related items for PubMed ID: 27693000

  • 1. High prevalence of nontoxigenic Clostridium difficile isolated from hospitalized and non-hospitalized individuals in rural Ghana.
    Janssen I, Cooper P, Gunka K, Rupnik M, Wetzel D, Zimmermann O, Groß U.
    Int J Med Microbiol; 2016 Dec; 306(8):652-656. PubMed ID: 27693000
    [Abstract] [Full Text] [Related]

  • 2. Toxin A-negative toxin B-positive ribotype 017 Clostridium difficile is the dominant strain type in patients with diarrhoea attending tuberculosis hospitals in Cape Town, South Africa.
    Kullin B, Wojno J, Abratt V, Reid SJ.
    Eur J Clin Microbiol Infect Dis; 2017 Jan; 36(1):163-175. PubMed ID: 27696234
    [Abstract] [Full Text] [Related]

  • 3. Diversity of Clostridium difficile PCR ribotypes in Europe: results from the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID), 2012 and 2013.
    Davies KA, Ashwin H, Longshaw CM, Burns DA, Davis GL, Wilcox MH, EUCLID study group.
    Euro Surveill; 2016 Jul 21; 21(29):. PubMed ID: 27470194
    [Abstract] [Full Text] [Related]

  • 4. Occurrence of Clostridium difficile ribotype 027 in hospitals of Silesia, Poland.
    Aptekorz M, Szczegielniak A, Wiechuła B, Harmanus C, Kuijper E, Martirosian G.
    Anaerobe; 2017 Jun 21; 45():106-113. PubMed ID: 28216085
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Molecular characterization, toxin detection and resistance testing of human clinical Clostridium difficile isolates from Lebanon.
    Berger FK, Rasheed SS, Araj GF, Mahfouz R, Rimmani HH, Karaoui WR, Sharara AI, Dbaibo G, Becker SL, von Müller L, Bischoff M, Matar GM, Gärtner B.
    Int J Med Microbiol; 2018 Apr 21; 308(3):358-363. PubMed ID: 29478838
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clinical impact of Clostridium difficile colonization.
    Hung YP, Lee JC, Lin HJ, Liu HC, Wu YH, Tsai PJ, Ko WC.
    J Microbiol Immunol Infect; 2015 Jun 21; 48(3):241-8. PubMed ID: 24890755
    [Abstract] [Full Text] [Related]

  • 9. A national survey of the molecular epidemiology of Clostridium difficile in Israel: the dissemination of the ribotype 027 strain with reduced susceptibility to vancomycin and metronidazole.
    Adler A, Miller-Roll T, Bradenstein R, Block C, Mendelson B, Parizade M, Paitan Y, Schwartz D, Peled N, Carmeli Y, Schwaber MJ.
    Diagn Microbiol Infect Dis; 2015 Sep 21; 83(1):21-4. PubMed ID: 26116225
    [Abstract] [Full Text] [Related]

  • 10. Laboratory diagnosis of Clostridium difficile associated diarrhoea and molecular characterization of clinical isolates.
    Russello G, Russo A, Sisto F, Scaltrito MM, Farina C.
    New Microbiol; 2012 Jul 21; 35(3):307-16. PubMed ID: 22842600
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Molecular epidemiology of Clostridium difficile infection in Iranian hospitals.
    Shoaei P, Shojaei H, Khorvash F, Hosseini SM, Ataei B, Tavakoli H, Jalali M, Weese JS.
    Antimicrob Resist Infect Control; 2019 Jul 21; 8():12. PubMed ID: 30675339
    [Abstract] [Full Text] [Related]

  • 13. Epidemiology of suspected Clostridium difficile-associated hospital-acquired diarrhea in hospitalized patients at Siriraj Hospital.
    Thipmontree W, Kiratisin P, Manatsathit S, Thamlikitkul V.
    J Med Assoc Thai; 2011 Feb 21; 94 Suppl 1():S207-16. PubMed ID: 21721449
    [Abstract] [Full Text] [Related]

  • 14. Risk factors for Clostridium difficile-associated diarrhea among hospitalized adults with fecal toxigenic C. difficile colonization.
    Lin HJ, Hung YP, Liu HC, Lee JC, Lee CI, Wu YH, Tsai PJ, Ko WC.
    J Microbiol Immunol Infect; 2015 Apr 21; 48(2):183-9. PubMed ID: 24064285
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotyping-based surveillance scheme in England.
    Wilcox MH, Shetty N, Fawley WN, Shemko M, Coen P, Birtles A, Cairns M, Curran MD, Dodgson KJ, Green SM, Hardy KJ, Hawkey PM, Magee JG, Sails AD, Wren MW.
    Clin Infect Dis; 2012 Oct 21; 55(8):1056-63. PubMed ID: 22784871
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Surveillance for antimicrobial resistance in Australian isolates of Clostridium difficile, 2013-14.
    Knight DR, Giglio S, Huntington PG, Korman TM, Kotsanas D, Moore CV, Paterson DL, Prendergast L, Huber CA, Robson J, Waring L, Wehrhahn MC, Weldhagen GF, Wilson RM, Riley TV.
    J Antimicrob Chemother; 2015 Nov 21; 70(11):2992-9. PubMed ID: 26221017
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.